KR102042296B1 - 신규한 비시클릭 티아졸 화합물 - Google Patents
신규한 비시클릭 티아졸 화합물 Download PDFInfo
- Publication number
- KR102042296B1 KR102042296B1 KR1020147032428A KR20147032428A KR102042296B1 KR 102042296 B1 KR102042296 B1 KR 102042296B1 KR 1020147032428 A KR1020147032428 A KR 1020147032428A KR 20147032428 A KR20147032428 A KR 20147032428A KR 102042296 B1 KR102042296 B1 KR 102042296B1
- Authority
- KR
- South Korea
- Prior art keywords
- substituted
- unsubstituted
- groups
- group
- thiazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 CN(*)c1nc(C(N*)=O)c(NC(*)=O)[s]1 Chemical compound CN(*)c1nc(C(N*)=O)c(NC(*)=O)[s]1 0.000 description 3
- IXZSWLSUBCWFMH-UHFFFAOYSA-N CCOC(c1c(N)[s]c(Nc2cc3ccccc3cc2)n1)=O Chemical compound CCOC(c1c(N)[s]c(Nc2cc3ccccc3cc2)n1)=O IXZSWLSUBCWFMH-UHFFFAOYSA-N 0.000 description 1
- FBWMVGNTIMVUKY-UHFFFAOYSA-N CCOC(c1c(NC(c2c[s]cc2)=O)[s]c(Nc2cc3cccc(OC)c3cc2)n1)=O Chemical compound CCOC(c1c(NC(c2c[s]cc2)=O)[s]c(Nc2cc3cccc(OC)c3cc2)n1)=O FBWMVGNTIMVUKY-UHFFFAOYSA-N 0.000 description 1
- URYZPSPUFSZXIE-UHFFFAOYSA-N CN(CC1)CCN1c(cc1)ccc1C(Nc1c(C(N)=O)nc(Nc2cc3cccnc3cc2)[s]1)=O Chemical compound CN(CC1)CCN1c(cc1)ccc1C(Nc1c(C(N)=O)nc(Nc2cc3cccnc3cc2)[s]1)=O URYZPSPUFSZXIE-UHFFFAOYSA-N 0.000 description 1
- ONPLEMFMYHGLLV-UHFFFAOYSA-N COc1cccc2c1ccc(Nc1nc(C(N)=O)c(NC(c3c[s]cc3)=O)[s]1)c2 Chemical compound COc1cccc2c1ccc(Nc1nc(C(N)=O)c(NC(c3c[s]cc3)=O)[s]1)c2 ONPLEMFMYHGLLV-UHFFFAOYSA-N 0.000 description 1
- WYMCYSYLZJVJSC-UHFFFAOYSA-N NC(c1c(NC(CCCCCBr)=O)[s]c(Nc2cc3ccccc3cc2)n1)=O Chemical compound NC(c1c(NC(CCCCCBr)=O)[s]c(Nc2cc3ccccc3cc2)n1)=O WYMCYSYLZJVJSC-UHFFFAOYSA-N 0.000 description 1
- FRWPHIBXHKLCTG-UHFFFAOYSA-N NC(c1c(NC(c(cc2)ccc2NC(CO)=O)=O)[s]c(Nc2cc3ccccc3cc2)n1)=O Chemical compound NC(c1c(NC(c(cc2)ccc2NC(CO)=O)=O)[s]c(Nc2cc3ccccc3cc2)n1)=O FRWPHIBXHKLCTG-UHFFFAOYSA-N 0.000 description 1
- SWVWUOUHDSLQBA-UHFFFAOYSA-N NC(c1c(NC(c(cc2)ccc2O)=O)[s]c(Nc2cc(cccc3)c3cc2)n1)=O Chemical compound NC(c1c(NC(c(cc2)ccc2O)=O)[s]c(Nc2cc(cccc3)c3cc2)n1)=O SWVWUOUHDSLQBA-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/479,396 US20130317218A1 (en) | 2012-05-24 | 2012-05-24 | Novel bicyclic thiazole compounds |
| US13/479,396 | 2012-05-24 | ||
| PCT/JP2013/064960 WO2013176293A1 (en) | 2012-05-24 | 2013-05-22 | Novel bicyclic thiazole compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR20150014931A KR20150014931A (ko) | 2015-02-09 |
| KR102042296B1 true KR102042296B1 (ko) | 2019-11-07 |
Family
ID=48628877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020147032428A Expired - Fee Related KR102042296B1 (ko) | 2012-05-24 | 2013-05-22 | 신규한 비시클릭 티아졸 화합물 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US20130317218A1 (https=) |
| EP (1) | EP2855470B1 (https=) |
| JP (1) | JP6095195B2 (https=) |
| KR (1) | KR102042296B1 (https=) |
| CN (1) | CN104321321B (https=) |
| WO (1) | WO2013176293A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130317218A1 (en) | 2012-05-24 | 2013-11-28 | Masaaki Sawa | Novel bicyclic thiazole compounds |
| WO2016202935A1 (en) * | 2015-06-19 | 2016-12-22 | Bayer Pharma Aktiengesellschaft | Glucose transport inhibitors |
| JP6881309B2 (ja) * | 2015-10-14 | 2021-06-02 | 日産化学株式会社 | 液晶配向剤、液晶配向膜、及び液晶表示素子 |
| WO2024111626A1 (ja) * | 2022-11-25 | 2024-05-30 | カルナバイオサイエンス株式会社 | 新規チアゾール誘導体 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100137386A1 (en) | 2008-12-01 | 2010-06-03 | Tesshi Yamada | Tnik inhibitor and the use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4038661B2 (ja) * | 2002-05-21 | 2008-01-30 | 株式会社大塚製薬工場 | ホスホン酸ジエステル誘導体 |
| US8323943B2 (en) * | 2008-02-21 | 2012-12-04 | National Cancer Center | Screening method for anticancer drug |
| US20130317218A1 (en) | 2012-05-24 | 2013-11-28 | Masaaki Sawa | Novel bicyclic thiazole compounds |
-
2012
- 2012-05-24 US US13/479,396 patent/US20130317218A1/en not_active Abandoned
-
2013
- 2013-05-22 US US14/403,071 patent/US9102637B2/en not_active Expired - Fee Related
- 2013-05-22 KR KR1020147032428A patent/KR102042296B1/ko not_active Expired - Fee Related
- 2013-05-22 EP EP13729492.2A patent/EP2855470B1/en not_active Not-in-force
- 2013-05-22 CN CN201380026183.8A patent/CN104321321B/zh not_active Expired - Fee Related
- 2013-05-22 WO PCT/JP2013/064960 patent/WO2013176293A1/en not_active Ceased
- 2013-05-22 JP JP2014556280A patent/JP6095195B2/ja not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100137386A1 (en) | 2008-12-01 | 2010-06-03 | Tesshi Yamada | Tnik inhibitor and the use |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104321321A (zh) | 2015-01-28 |
| WO2013176293A1 (en) | 2013-11-28 |
| US20150133656A1 (en) | 2015-05-14 |
| EP2855470B1 (en) | 2018-10-17 |
| US9102637B2 (en) | 2015-08-11 |
| CN104321321B (zh) | 2017-07-07 |
| JP6095195B2 (ja) | 2017-03-15 |
| JP2015517453A (ja) | 2015-06-22 |
| EP2855470A1 (en) | 2015-04-08 |
| US20130317218A1 (en) | 2013-11-28 |
| KR20150014931A (ko) | 2015-02-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2524401C (en) | Thiazole derivatives as inhibitors of phosphatidylinositol 3-kinase | |
| WO2013027168A1 (en) | Novel heterocyclic compounds as bromodomain inhibitors | |
| CN108727363B (zh) | 一种新型细胞周期蛋白依赖性激酶cdk9抑制剂 | |
| US20040229889A1 (en) | HDAC inhibitor | |
| CN102164920B (zh) | 烷基噻唑氨基甲酸酯衍生物、其制备方法和其作为faah酶抑制剂的用途 | |
| CN1834095B (zh) | 一类非核苷类抗病毒抑制剂及其制备方法和用途 | |
| CN104844589B (zh) | 一种pi3k激酶抑制剂 | |
| KR102042296B1 (ko) | 신규한 비시클릭 티아졸 화합물 | |
| CN101490033A (zh) | 用于治疗对嗜中性白细胞弹性蛋白酶活性的抑制是有益的疾病或病症的2-吡啶酮衍生物 | |
| KR20140064982A (ko) | eIF4E 억제제로서의 벤조산 유도체 | |
| AU2008278966A1 (en) | Pyrimidine derivatives useful for the treatment of inflammatory or allergic conditions | |
| CN103058949A (zh) | 做为dhodh抑制剂的噻唑衍生物及其应用 | |
| CN113166105B (zh) | 作为cdk-hdac双通路抑制剂的杂环化合物 | |
| CN110194770A (zh) | 肽酰精氨酸脱亚胺酶抑制剂及其用途 | |
| ES2223884T3 (es) | Derivados de pirazinona. | |
| WO2010064111A1 (en) | Tnik inhibitor and the use | |
| CA2655568A1 (en) | Organic compounds | |
| CN109810098A (zh) | 含有酞嗪-1(2h)-酮结构的parp-1和pi3k双靶点抑制剂 | |
| CA2631051A1 (en) | Organic compounds | |
| EP3632912B1 (en) | Pyridoquinazoline derivatives useful as protein kinase inhibitors | |
| JP2008545690A (ja) | 新規化合物 | |
| AU2007288188A1 (en) | 4-thio substituted quinoline and naphthyridine compounds | |
| KR102218861B1 (ko) | 단백질 키나아제 저해제인 신규한 페녹시 아로마틱 아마이드 유도체 | |
| WO2025007769A1 (zh) | 作为CDKs抑制剂的苯并三唑衍生物及其药物组合物和应用 | |
| EP1984361A1 (fr) | Derives de 2-carbamide-4-phenylthiazole, leur preparation et leur application en therapeutique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0105 | International application |
St.27 status event code: A-0-1-A10-A15-nap-PA0105 |
|
| PG1501 | Laying open of application |
St.27 status event code: A-1-1-Q10-Q12-nap-PG1501 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| PN2301 | Change of applicant |
St.27 status event code: A-3-3-R10-R13-asn-PN2301 St.27 status event code: A-3-3-R10-R11-asn-PN2301 |
|
| A201 | Request for examination | ||
| PA0201 | Request for examination |
St.27 status event code: A-1-2-D10-D11-exm-PA0201 |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
St.27 status event code: A-1-2-D10-D22-exm-PE0701 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
St.27 status event code: A-2-4-F10-F11-exm-PR0701 |
|
| PR1002 | Payment of registration fee |
St.27 status event code: A-2-2-U10-U12-oth-PR1002 Fee payment year number: 1 |
|
| PG1601 | Publication of registration |
St.27 status event code: A-4-4-Q10-Q13-nap-PG1601 |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: A-4-4-U10-U13-oth-PC1903 Not in force date: 20221102 Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE |
|
| PC1903 | Unpaid annual fee |
St.27 status event code: N-4-6-H10-H13-oth-PC1903 Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE Not in force date: 20221102 |